YDES
NASDAQ · Biotechnology
Yd Bio Ltd
$5.31
+0.02 (+0.35%)
Open$5.21
Previous Close$5.29
Day High$5.31
Day Low$5.21
52W High$25.00
52W Low$4.73
Volume—
Avg Volume5.6K
Market Cap373.16M
P/E Ratio—
EPS$-1.03
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 559.7K | 122.20M | 119.09M |
| Net Income | -1,554,849 | 29.08M | 25.78M |
| Profit Margin | -276.6% | 23.8% | 21.7% |
| EBITDA | -1,531,526 | 41.35M | 38.15M |
| Free Cash Flow | — | 33.20M | 25.74M |
| Rev Growth | — | +2.9% | +5.6% |
| Debt/Equity | 0.01 | 0.45 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |